Blockade of A(2A) receptors potently suppresses the metastasis of CD73( ) tumors
Paul A Beavis, Upulie Divisekera, Christophe Paget, Melvyn T Chow, Liza B John, Christel Devaud, Karen Dwyer, John Stagg, Mark J Smyth, Phillip K Darcy
Proceedings of the National Academy of Sciences of the United States of America | NATL ACAD SCIENCES | Published : 2013
The authors acknowledge the assistance of the Peter MacCallum Cancer Centre Experimental Animal facility technicians for animal care, the Histology Department (Peter MacCallum Cancer Centre) for the processing of hematoxylin and eosin sections of lung tissue, and Dr. Delphine Denoyer for her assistance with TLC analysis. The authors also acknowledge Bayer for provision of the A<INF>2B</INF> agonist BAY60-6583. This work was funded by project grants from the National Health and Medical Research Council (NHMRC) and Susan G. Komen for the Cure, an American Department of Defense Breast Cancer Fellowship (to C.P.), an NHMRC Australian Research Fellowship (to M.J.S. and P.A.B.), an NHMRC Senior Research Fellowship (to P.K.D.), and a Famille Sabourin Research Chair of University of Montreal and Operating Grant from the Canadian Institutes of Health Research (to J.S.).